Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLSEN, Elise A.
dc.contributor.authorWHITTAKER, Sean
dc.contributor.authorKIM, Youn H.
dc.contributor.authorDUVIC, Madeleine
dc.contributor.authorPRINCE, H. Miles
dc.contributor.authorLESSIN, Stuart R.
dc.contributor.authorWOOD, Gary S.
dc.contributor.authorWILLEMZE, Rein
dc.contributor.authorDEMIERRE, Marie-France
dc.contributor.authorPIMPINELLI, Nicola
dc.contributor.authorBERNENGO, Maria Grazia
dc.contributor.authorORTIZ-ROMERO, Pablo L.
dc.contributor.authorBAGOT, Martine
dc.contributor.authorESTRACH, Teresa
dc.contributor.authorGUITART, Joan
dc.contributor.authorKNOBLER, Robert
dc.contributor.authorSANCHES, Jose Antonio
dc.contributor.authorIWATSUKI, Keiji
dc.contributor.authorSUGAYA, Makoto
dc.contributor.authorDUMMER, Reinhard
dc.contributor.authorPITTELKOW, Mark
dc.contributor.authorHOPPE, Richard
dc.contributor.authorPARKER, Sareeta
dc.contributor.authorGESKIN, Larisa
dc.contributor.authorPINTER-BROWN, Lauren
dc.contributor.authorGIRARDI, Michael
dc.contributor.authorBURG, Guenter
dc.contributor.authorRANKI, Annamari
dc.contributor.authorVERMEER, Maartan
dc.contributor.authorHORWITZ, Steven
dc.contributor.authorHEALD, Peter
dc.contributor.authorROSEN, Steve
dc.contributor.authorCERRONI, Lorenzo
dc.contributor.authorDRENO, Brigette
dc.contributor.authorVONDERHEID, Eric C.
dc.date.accessioned2017-11-27T16:26:14Z
dc.date.available2017-11-27T16:26:14Z
dc.date.issued2011
dc.description.abstractMycosis fungoides (MF) and Sezary syndrome (SS), the major forms of cutaneous T-cell lymphoma, have unique characteristics that distinguish them from other types of non-Hodgkin's lymphomas. Clinical trials in MF/SS have suffered from a lack of standardization in evaluation, staging, assessment, end points, and response criteria. Recently defined criteria for the diagnosis of early MF, guidelines for initial evaluation, and revised staging and classification criteria for MF and SS now offer the potential for uniform staging of patients enrolled in clinical trials for MF/SS. This article presents consensus recommendations for the general conduct of clinical trials of patients with MF/SS as well as methods for standardized assessment of potential disease manifestations in skin, lymph nodes, blood, and visceral organs, and definition of end points and response criteria. These guidelines should facilitate collaboration among investigators and collation of data from sponsor-generated or investigator-initiated clinical trials involving patients with MF or SS. J Clin Oncol 29:2598-2607. (C) 2011 by American Society of Clinical Oncology
dc.description.indexMEDLINE
dc.description.sponsorshipBioCryst
dc.description.sponsorshipEisai
dc.description.sponsorshipJohnson Johnson
dc.description.sponsorshipYaupon Therapeutics
dc.description.sponsorshipGenmab
dc.description.sponsorshipGloucester Pharmaceuticals
dc.description.sponsorshipMerck
dc.description.sponsorshipAllos Therapeutics
dc.description.sponsorshipEli Lilly
dc.description.sponsorshipTenX Biopharma
dc.description.sponsorshipTherakos
dc.description.sponsorshipRoche
dc.description.sponsorshipNovartis
dc.identifier.citationJOURNAL OF CLINICAL ONCOLOGY, v.29, n.18, p.2598-2607, 2011
dc.identifier.doi10.1200/JCO.2010.32.0630
dc.identifier.issn0732-183X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/22927
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsrestrictedAccess
dc.rights.holderCopyright AMER SOC CLINICAL ONCOLOGY
dc.subject.othert-cell lymphoma
dc.subject.otherof-life measure
dc.subject.otherperipheral-blood
dc.subject.otherexpression
dc.subject.otherdisease
dc.subject.otherclassification
dc.subject.otherdiagnosis
dc.subject.otherphase
dc.subject.othertrial
dc.subject.otheridentification
dc.subject.wosOncology
dc.titleClinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryÁustria
hcfmusp.affiliation.countryJapão
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryFinlândia
hcfmusp.affiliation.countryHolanda
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisonl
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoat
hcfmusp.affiliation.countryisojp
hcfmusp.affiliation.countryisoch
hcfmusp.affiliation.countryisofi
hcfmusp.author.externalOLSEN, Elise A.:Duke Univ, Med Ctr, Durham, NC 27710 USA
hcfmusp.author.externalWHITTAKER, Sean:Kings Coll London, Guys & St Thomas Natl Hlth Serv Fdn Trust, St Johns Inst Dermatol, London, England
hcfmusp.author.externalKIM, Youn H.:Stanford Canc Ctr, Stanford, CA USA
hcfmusp.author.externalDUVIC, Madeleine:Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
hcfmusp.author.externalPRINCE, H. Miles:Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Univ Melbourne, Melbourne, Vic, Australia
hcfmusp.author.externalLESSIN, Stuart R.:Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
hcfmusp.author.externalWOOD, Gary S.:Univ Wisconsin, Madison, WI USA; VA Med Ctr, Madison, WI USA
hcfmusp.author.externalWILLEMZE, Rein:Leiden Univ, Med Ctr, Leiden, Netherlands
hcfmusp.author.externalDEMIERRE, Marie-France:Boston Univ, Boston, MA 02215 USA
hcfmusp.author.externalPIMPINELLI, Nicola:Univ Florence, Sch Med, I-50121 Florence, Italy
hcfmusp.author.externalBERNENGO, Maria Grazia:Univ Turin, Turin, Italy
hcfmusp.author.externalORTIZ-ROMERO, Pablo L.:Univ Complutense, E-28040 Madrid, Spain
hcfmusp.author.externalBAGOT, Martine:Hop St Louis, Paris, France
hcfmusp.author.externalESTRACH, Teresa:Univ Barcelona, IDIBAPS, Hosp Clin, Barcelona, Spain
hcfmusp.author.externalKNOBLER, Robert:Med Univ Vienna, Vienna, Austria
hcfmusp.author.externalIWATSUKI, Keiji:Okayama Univ, Okayama, Japan
hcfmusp.author.externalSUGAYA, Makoto:Univ Tokyo, Tokyo, Japan
hcfmusp.author.externalDUMMER, Reinhard:Univ Zurich, Zurich, Switzerland
hcfmusp.author.externalPITTELKOW, Mark:Mayo Clin, Coll Med, Rochester, MN USA
hcfmusp.author.externalHOPPE, Richard:Stanford Univ, Stanford, CA 94305 USA
hcfmusp.author.externalPARKER, Sareeta:Emory Univ, Sch Med, Atlanta, GA USA
hcfmusp.author.externalGESKIN, Larisa:Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
hcfmusp.author.externalPINTER-BROWN, Lauren:Univ Calif Los Angeles, Los Angeles, CA USA
hcfmusp.author.externalGIRARDI, Michael:Yale Univ, Sch Med, New Haven, CT USA
hcfmusp.author.externalBURG, Guenter:Univ Zurich, Zurich, Switzerland
hcfmusp.author.externalRANKI, Annamari:Univ Helsinki, Skin & Allergy Hosp, Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland
hcfmusp.author.externalVERMEER, Maartan:Leiden Univ, Med Ctr, Leiden, Netherlands
hcfmusp.author.externalHORWITZ, Steven:Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
hcfmusp.author.externalHEALD, Peter:Yale Univ, Sch Med, New Haven, CT USA
hcfmusp.author.externalROSEN, Steve:Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
hcfmusp.author.externalCERRONI, Lorenzo:Med Univ Graz, Graz, Austria
hcfmusp.author.externalDRENO, Brigette:Univ Hosp, U892, Nantes, France
hcfmusp.author.externalVONDERHEID, Eric C.:Johns Hopkins Med Inst, Baltimore, MD 21205 USA
hcfmusp.citation.scopus523
hcfmusp.contributor.author-fmusphcJOSE ANTONIO SANCHES JUNIOR
hcfmusp.description.beginpage2598
hcfmusp.description.endpage2607
hcfmusp.description.issue18
hcfmusp.description.volume29
hcfmusp.origemWOS
hcfmusp.origem.pubmed21576639
hcfmusp.origem.scopus2-s2.0-79959290992
hcfmusp.origem.wosWOS:000291684600038
hcfmusp.publisher.cityALEXANDRIA
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceCheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403
hcfmusp.relation.referenceWillemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502
hcfmusp.relation.referenceSAUSVILLE EA, 1988, ANN INTERN MED, V109, P372
hcfmusp.relation.referenceKim YH, 2003, ARCH DERMATOL, V139, P857, DOI 10.1001/archderm.139.7.857
hcfmusp.relation.referenceBUNN PA, 1979, CANCER TREAT REP, V63, P725
hcfmusp.relation.referenceHarmon CB, 1996, J AM ACAD DERMATOL, V35, P404, DOI 10.1016/S0190-9622(96)90605-2
hcfmusp.relation.referenceLUTZNER M, 1975, ANN INTERN MED, V83, P534
hcfmusp.relation.referenceSCHECHTER GP, 1987, BLOOD, V69, P841
hcfmusp.relation.referenceOlsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434
hcfmusp.relation.referenceVonderheid EC, 2002, J AM ACAD DERMATOL, V46, P95, DOI 10.1067/mjd.2002.118538
hcfmusp.relation.referenceOlsen E, 2001, J CLIN ONCOL, V19, P376
hcfmusp.relation.referenceDummer R, 1999, ARCH DERMATOL RES, V291, P307, DOI 10.1007/s004030050414
hcfmusp.relation.referenceCheson BD, 1996, BLOOD, V87, P4990
hcfmusp.relation.referenceChren MM, 2001, J CUTAN MED SURG, V5, P105, DOI 10.1007/s102270000010
hcfmusp.relation.referenceChren MM, 1996, J INVEST DERMATOL, V107, P707, DOI 10.1111/1523-1747.ep12365600
hcfmusp.relation.referencePimpinelli N, 2005, J AM ACAD DERMATOL, V53, P1053, DOI 10.1016/j.jaad.2005.08.057
hcfmusp.relation.referenceBogen SA, 1996, AM J CLIN PATHOL, V106, P739
hcfmusp.relation.referenceEisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026
hcfmusp.relation.referenceDemierre MF, 2005, ARCH DERMATOL, V141, P325
hcfmusp.relation.referenceDuvic M, 2001, ARCH DERMATOL, V137, P581
hcfmusp.relation.referenceSACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4
hcfmusp.relation.referenceOlsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749
hcfmusp.relation.referenceJones D, 2001, AM J CLIN PATHOL, V115, P885
hcfmusp.relation.referenceStevens SR, 2002, ARCH DERMATOL, V138, P42, DOI 10.1001/archderm.138.1.42
hcfmusp.relation.referenceBernengo MG, 2001, BRIT J DERMATOL, V144, P125, DOI 10.1046/j.1365-2133.2001.04014.x
hcfmusp.relation.referenceBOROWITZ MJ, 1993, LEUKEMIA, V7, P859
hcfmusp.relation.referenceBrenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149
hcfmusp.relation.referenceDuncan K, 1998, J INVEST DERMATOL, V110, P645
hcfmusp.relation.referenceEDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603
hcfmusp.relation.referenceGobbi PG, 2002, HAEMATOLOGICA, V87, P1151
hcfmusp.relation.referenceGOROCHOV G, 1995, J INVEST DERMATOL, V105, P56, DOI 10.1111/1523-1747.ep12312560
hcfmusp.relation.referenceHopper KD, 1996, AM J ROENTGENOL, V167, P851
hcfmusp.relation.referenceKUKEL S, 1994, CLIN EXP IMMUNOL, V98, P163
hcfmusp.relation.referenceLEWIS E, 1982, J COMPUT ASSIST TOMO, V6, P792, DOI 10.1097/00004728-198208000-00025
hcfmusp.relation.referenceReinhold U, 1997, J CLIN IMMUNOL, V17, P265, DOI 10.1023/A:1027318530127
hcfmusp.relation.referenceRIEGER E, 1989, J CUTAN PATHOL, V16, P7, DOI 10.1111/j.1600-0560.1989.tb00002.x
hcfmusp.relation.referenceSteinhoff M, 2009, LEUKEMIA RES, V33, P88, DOI 10.1016/j.leukres.2008.06.025
hcfmusp.relation.referenceVonderheid EC, 2001, J INVEST DERMATOL, V117, P654, DOI 10.1046/j.1523-1747.2001.01456.x
hcfmusp.relation.referenceVonderheid EC, 2006, LEUKEMIA LYMPHOMA, V47, P1841, DOI 10.1080/10428190600709655
hcfmusp.relation.referenceVonderheid EC, 2003, HEMATOL ONCOL CLIN N, V17, P1367, DOI 10.1016/S0889-8588(03)00120-5
hcfmusp.relation.referenceZACKHEIM HS, 1995, HEMATOL ONCOL CLIN N, V9, P1021
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationae881f0f-f988-4f6b-be2e-f0a5d81c9d3b
relation.isAuthorOfPublication.latestForDiscoveryae881f0f-f988-4f6b-be2e-f0a5d81c9d3b
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_OLSEN_Clinical_End_Points_and_Response_Criteria_in_Mycosis_2011.PDF
Tamanho:
113.76 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/53